págs. 405-407
Why cerebellar glioblastoma is rare and how that indicates adjunctive use of the FDA-approved anti-emetic aprepitant might retard cerebral glioblastoma growth:: a new hypothesis to an old question
págs. 408-410
págs. 411-427
págs. 428-436
págs. 437-445
págs. 446-454
mTOR inhibitors and the anti-diabetic biguanide metformin:: new insights into the molecular management of breast cancer resistance to the HER2 tyrosine kinase inhibitor lapatinib ( Tykerb)
págs. 455-459
Initial surgical experience in laparoscopic total mesorectal excision for middle and lower third rectal cancer:: short-term results
págs. 460-464
págs. 465-469
Quality of life two years after radical prostatectomy, prostate brachytherapy or external beam radiotherapy for clinically localised prostate cancer:: the Catalan Institute of Oncology/Bellvitge Hospital experience
págs. 470-478
págs. 479-483
págs. 484-485
págs. 486-487
© 2001-2024 Fundación Dialnet · Todos los derechos reservados